Keyphrases
Age Groups
20%
All Ages
20%
Cancer Types
40%
Caucasian Population
20%
Class Ib
20%
Drug Treatment
20%
Human Leukocyte Antigen
100%
Human Leukocyte antigen-G (HLA-G)
100%
Immunologic Therapy
20%
Immunological Interaction
20%
Malignant Melanoma
100%
Pathophysiological Mechanisms
20%
Pharmaceutical Drugs
20%
Prognostic Outcome
20%
Regulatory T Cells
100%
Risk Factors
20%
Tumor Progression
40%
Young Subgroup
20%
Medicine and Dentistry
Diseases
33%
Downregulation
16%
Drug Therapy
16%
Human Leukocyte Antigen
100%
Immunotherapy
16%
Malignant Neoplasm
50%
Melanoma
100%
Regulatory T Cell
100%
Tumor Progression
33%
Upregulation
16%
Immunology and Microbiology
Downregulation
16%
Drug Therapy
16%
Human Leukocyte Antigen
100%
Immunotherapy
16%
Regulatory T Cell
100%
Upregulation
16%